Scrafton, E; Barber, C; Heghes, C;
Acrostic is a scientifically robust read-across solution designed to enhance decision-making in establishing acceptable intake (AI) limits for novel and untested nitrosamines.
Discover the benefits of integrating Acrostic into your nitrosamine risk assessment strategy with our infographic.
Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK
Tel: +44 (0)113 394 6020
© 2024 Lhasa Limited, All rights reserved | Company registration number: 01765239 |
VAT number: 396 8737 77 | Registered charity number: 290866 | Governing documents